Related Experiment Video
Updated: Aug 15, 2026

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
Published on: December 6, 2016
Role of perivascular cells and myocytes in vascular amyloidosis
H M Wisniewski1, J Wegiel, A W Vorbrodt
1New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314, USA.
Abstract:
Amyloidogenic processing of amyloid-beta precursor protein (APP) by cells of the brain is the major pathologic component of Alzheimer's disease. Amyloid-beta (A beta) is of heterogeneous origin. Perivascular cells of monocyte-macrophage-microglial cell lineage produce fibrillar A beta in the wall of capillaries, whereas parenchymal microglial cells produce fibrillar A beta in the parenchyma of gray matter. Fibrillar A beta deposition by perivascular cells lead to endothelial cell degeneration and death, obliteration of affected capillaries, and reduction of the length of the vascular network. These changes cause local ischemia with neuronal degeneration and death. Smooth muscle cells are the source of A beta in the tunica media of parenchymal and leptomeningeal arteries and veins. Fibrillar A beta in the tunica media of leptomeningeal and parenchymal vessels causes degeneration and necrosis of smooth muscle cells and leads to multiple cortical hemorrhages. Smooth muscle cells isolated from blood vessels with amyloid deposits secrete A beta and accumulate nonfibrillar A beta intracellularly. The amyloidogenic processing of APP can be enhanced by apolipoprotein E, reduced by transthyretin, and modulated by several cytokines.
Insights
Alzheimer's disease involves amyloid-beta (A beta) production by brain cells. Different cell types generate A beta, impacting brain vasculature and leading to neuronal damage and hemorrhages.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Alzheimer's disease (AD) pathology is characterized by amyloidogenic processing of amyloid-beta precursor protein (APP).
- Amyloid-beta (A beta) originates from diverse cellular sources within the brain.
Purpose of the Study:
- To elucidate the cellular origins and pathogenic mechanisms of amyloid-beta (A beta) deposition in the brain.
- To understand the role of different cell types in the development of Alzheimer's disease (AD) pathology.
Main Methods:
- Investigated the cellular sources of fibrillar A beta in brain capillaries and parenchyma.
- Examined the role of smooth muscle cells in A beta deposition in cerebral blood vessels.
- Analyzed the impact of A beta deposition on vascular integrity and neuronal survival.
Main Results:
- Perivascular cells (monocyte-macrophage-microglial lineage) produce fibrillar A beta in capillaries, causing endothelial cell death and vascular network reduction.
- Parenchymal microglial cells generate fibrillar A beta in gray matter parenchyma.
- Smooth muscle cells in arteries and veins contribute to A beta deposition, leading to smooth muscle cell necrosis and cortical hemorrhages.
- Isolated smooth muscle cells secrete A beta and accumulate it intracellularly.
Conclusions:
- Heterogeneous cellular origins of A beta contribute to distinct pathological features in Alzheimer's disease (AD).
- Vascular A beta deposition by perivascular and smooth muscle cells drives critical pathologies including ischemia and hemorrhage.
- Amyloidogenic APP processing is influenced by factors like apolipoprotein E, transthyretin, and cytokines.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Myocarditis I: Introduction
Atherosclerosis I: Introduction

